Search research articles
Contact Us
Filters
Showing results (321-330 of 355) with videos related to
Page
of 36
Sort By:
The New England Journal of Medicine
|
June 22, 2022
Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study
Beate Schmoele-Thoma, Agnieszka M Zareba, Qin Jiang, et al.
The Pediatric Infectious Disease Journal
|
December 1, 2016
Circulating Antibody 1 and 2 Years After Vaccination With the 13-Valent Pneumococcal Conjugate Vaccine in Preterm Compared With Term Infants
Federico Martinón-Torres, Jacek Wysocki, Kimberly J Center, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 28, 2023
A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds
Lisa Usdan, Sohil Patel, Hector Rodriguez, et al.
The Pediatric Infectious Disease Journal
|
June 29, 2007
Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia
John S Tam, Maria Rosario Z Capeding, Lucy Chai See Lum, et al.
Journal of Medicinal Chemistry
|
December 28, 2002
Synthesis and structure-activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2)
Allan Wissner, Elsebe Overbeek, Marvin F Reich, et al.
Nature Communications
|
November 23, 2024
BTK regulates microglial function and neuroinflammation in human stem cell models and mouse models of multiple sclerosis
Ross C Gruber, Gregory S Wirak, Anna S Blazier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2023
Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial
Hamid Hassanzadeh, James Baber, Elizabeth Begier, et al.
Scientific Reports
|
January 14, 2023
Optimizing variant-specific therapeutic SARS-CoV-2 decoys using deep-learning-guided molecular dynamics simulations
Katharina Köchl, Tobias Schopper, Vedat Durmaz, et al.
Pediatric Blood & Cancer
|
March 27, 2015
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study
Mariane De Montalembert, Miguel R Abboud, Anne Fiquet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 24, 2024
CLOVER (CLOstridium difficile Vaccine Efficacy tRial) Study: A Phase 3, Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of Clostridioides difficile Infection
Curtis J Donskey, Erik R Dubberke, Nicola P Klein, et al.
Page
of 36
Search research articles
Search
Showing results (321-330 of 355) with videos related to
Sort By:
Page
of 36
The New England Journal of Medicine
|
June 22, 2022
Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study
Beate Schmoele-Thoma, Agnieszka M Zareba, Qin Jiang, et al.
The Pediatric Infectious Disease Journal
|
December 1, 2016
Circulating Antibody 1 and 2 Years After Vaccination With the 13-Valent Pneumococcal Conjugate Vaccine in Preterm Compared With Term Infants
Federico Martinón-Torres, Jacek Wysocki, Kimberly J Center, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 28, 2023
A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds
Lisa Usdan, Sohil Patel, Hector Rodriguez, et al.
The Pediatric Infectious Disease Journal
|
June 29, 2007
Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia
John S Tam, Maria Rosario Z Capeding, Lucy Chai See Lum, et al.
Journal of Medicinal Chemistry
|
December 28, 2002
Synthesis and structure-activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2)
Allan Wissner, Elsebe Overbeek, Marvin F Reich, et al.
Nature Communications
|
November 23, 2024
BTK regulates microglial function and neuroinflammation in human stem cell models and mouse models of multiple sclerosis
Ross C Gruber, Gregory S Wirak, Anna S Blazier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2023
Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial
Hamid Hassanzadeh, James Baber, Elizabeth Begier, et al.
Scientific Reports
|
January 14, 2023
Optimizing variant-specific therapeutic SARS-CoV-2 decoys using deep-learning-guided molecular dynamics simulations
Katharina Köchl, Tobias Schopper, Vedat Durmaz, et al.
Pediatric Blood & Cancer
|
March 27, 2015
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study
Mariane De Montalembert, Miguel R Abboud, Anne Fiquet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 24, 2024
CLOVER (CLOstridium difficile Vaccine Efficacy tRial) Study: A Phase 3, Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of Clostridioides difficile Infection
Curtis J Donskey, Erik R Dubberke, Nicola P Klein, et al.
Page
of 36